¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"amino acid activating enzyme"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • boric acid
    ºØ»ê
  • boric acid ointment
    ºØ»ê¿¬°í
  • boric acid poisoning
    ºØ»êÁßµ¶
  • butyric acid
    ºÎƼ¸£»ê
  • cacodylic acid
    Ä«ÄÚµô»ê
  • citric acid
    ½ÃÆ®¸£»ê, ±¸¿¬»ê
  • citric acid cycle
    ½ÃÆ®¸£»êȸ·Î, ±¸¿¬»êȸ·Î
  • carbamic acid
    Ä«¸£¹Ù¹Î»ê
  • carbolic acid
    ¼®Åº»ê
  • carbolic acid gangrene
    ¼®Åº»ê±«Àú
  • conjugated acid
    ¦»ê, °áÇÕ»ê
  • carbonic acid
    ź»ê
  • caffeic acid
    Ä«ÆäÀλê
  • corrosive acid
    ºÎ½Ä»ê
  • cyanuric acid
    ½Ã¾Æ´©¸£»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • caffeic acid
    Ä«ÆäÀλê
  • carbolic acid
    (¢¡phenol) Æä³î, ¼®Åº»ê
  • carbonic acid
    ź»ê
  • chamber acid
    ¿¬½ÇȲ»ê
  • chitonic acid
    Űſ»ê
  • cholic acid
    ´ãÁó»ê
  • citric acid
    ±¸¿¬»ê, ½ÃÆ®¸£»ê
  • conjugated acid
    ¦»ê, °ø¾×»ê, °áÇÕ»ê
  • corrosive acid
    ºÎ½Ä»ê
  • cyanuric acid
    ½Ã¾Æ´©¸£»ê
  • cyclopaldic acid
    ½ÃŬ·ÎÆÈµå»ê
  • deoxycholic acid
    µð¿Á½ÃÄݸ°»ê
  • deoxyribonucleic acid
    µð¿Á½Ã¸®º¸ÇÙ»ê, µð¿£¿¡ÀÌ
  • desoxyribonucleic acid
    (¢¡deoxyribonucleic acid) µð¿Á½Ã¸®º¸ÇÙ»ê, µð¿£¿¡ÀÌ
  • dibasic acid
    ÀÌ¿°±â»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • acid elution slide test
    »ê¿ëÃâ½½¶óÀ̵å½ÃÇè
  • acid error
    »ê¿ÀÂ÷(ß«è¦ó¬).
  • acid fast
    Ç×»ê(¼º)(ù÷ß«àõ)ÀÇ.
  • acid fast bacillus (AFB)
    Ç×»ê±Õ, Ç׻긷´ë±Õ
  • acid fast bacterium
    Ç×»ê(¼º) ¼¼±Õ.
  • acid fast bacterium
    Ç×»ê(¼º) ¼¼±Õ.
  • acid fast organism
    Ç×»ê±Õ
  • acid fast stain
    Ç×»ê(¼º) ¿°»ö(¡­æøßä).
  • acid fastness
    Ç׻꼺
  • acid food
    »ê¼º½Äǰ.
  • acid forming
    »ê¹ß»ý(ß«Û¡ßæ)ÀÇ.
  • acid free diet
    ¹«»ê½ÄÀÌ.
  • acid hematin method
    »êÇ츶ƾ¹ý(¡­Ûö).
  • acid intoxication
    »êÁßµ¶(Áõ)(ß«ñéÔ¸ñø).
  • acid lipase deficiency
    »ê¼º ¸®ÆÄÁ¦ °áÇÌÁõ(ß«àõ¡­ÌÀù¹ñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • enzyme-multiplied/mediated immunoassay
    È¿¼Ò´ÙÁß/¸Å°³ ¸é¿ªÃøÁ¤(¹ý)
  • erythrocyte enzyme deficiency
    ÀûÇ÷±¸È¿¼Ò°áÇÌÁõ
  • extracellular enzyme
    ¼¼Æ÷¿ÜÈ¿¼Ò, ü¿ÜÈ¿¼Ò
  • fibrinolytic enzyme
    ¼¶À¯¼Ò¿ëÇØÈ¿¼Ò.
  • flavin enzyme
    Ç÷¹À̺óÈ¿¼Ò.
  • glycine cleavage enzyme system
  • glycolytic enzyme
    ÇØ´çÈ¿¼Ò
  • glycolytic enzyme
    ÇØ´çÈ¿¼Ò.
  • heterogeneous enzyme immunoassay
    ºÒ±ÕÀÏ<--Áú>È¿¼Ò¸é¿ªÇÐÀûÃøÁ¤(¹ý)
  • homogeneous enzyme immunoassay
    ±ÕÁúÈ¿¼Ò¸é¿ªÃøÁ¤(¹ý)
  • induced enzyme
    À¯µµÈ¿¼Ò.
  • inducible enzyme
    À¯¹ß°¡´ÉÈ¿¼Ò
  • inducible enzyme
    À¯µµ(¹ß)È¿¼Ò.
  • inhibitory enzyme
    ÀúÇØÈ¿¼Ò.
  • inorganic enzyme
    ¹«±âÈ¿¼Ò(ÙíѦý£áÈ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • early enzyme
    Á¶±â È¿¼Ò(ðÄÑ¢ý£áÈ)
  • enzyme
    È¿¼Ò(ý£áÈ)
  • enzyme I
    È¿¼Ò(ý£áÈ) I
  • enzyme II
    È¿¼Ò(ý£áÈ) II
  • enzyme III
    È¿¼Ò(ý£áÈ) III
  • enzyme adaptation
    È¿¼Ò ÀûÀÀ(ý£áÈîêëë)
  • enzyme amplification
    È¿¼Ò ÁõÆø(ý£áÈñòøë)
  • enzyme analogue
    È¿¼ÒÀ¯»çü(ý£áÈëºÞÄô÷)
  • enzyme assay
    È¿¼Ò(ý£áÈ)¾Æ½êÀÌ
  • enzyme-bridge complex
    È¿¼Ò°¡±³ º¹ÇÕü (ý£áÈÊ­ÎéÜÜùêô÷)
  • enzyme cascade
    È¿¼Ò(ý£áÈ) ÄɽºÄÉÀ̵å
  • enzyme classification
    È¿¼Ò ºÐ·ù(ý£áÈÝÂ×¾)
  • Enzyme Commission
    È¿¼Ò ºÐ°úÀ§¿øÈ¸ (ý£áÈÝÂΡêÍê¬üå)
  • enzyme complex
    È¿¼Òº¹ÇÕü (ý£áÈÜÜùêô÷)
  • enzyme concentration
    È¿¼Ò³óµµ (ý£áÈÒØÓø)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
AADC amino acid decarboxylase
AAM acute aseptic meningitis; American Academy of Microbiology; amino acid mixture; African American Mal...
AAO American Academy of Osteopathy; American Academy of Ophthalmology; American Academy of Optometry; Am...
aa seq amino acid sequence
AOAA amino-oxyacetic acid
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
GABA(A) gamma-amino-n-butyric acid
L-AP-4 L-amino-4-phosphonobutyric acid
L-AP4 L(+)-2-amino-4-phosphonobutanoic acid
LAO L-Amino acid oxidase
LNAA Large neutral amino acid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chondroitin sulfuric acid
    Äܵå·ÎÀÌÆ¾ Ȳ»ê
    LeveneÀÌ ºÙÀÎ ±¸Á¶½ÄÀ¸·Î, ¿¬°ñÀÇ À¯Á¡Ã¼¿¡ µé¾î ÀÖ´Â ´ç´Ü¹éÁúÀÇ ¹èÇÕÁ·. °­ÇÏ°Ô °¡¼öºÐÇØÇϸé Äܵå·Î»ç¹Î, ÃÊ»ê, ±Û·çÄí·Ð»ê, Ȳ»êÀÌ »ý±ä´Ù.
  • chronic acid
    Å©·Ò»ê
  • conjugate acid
    ¦»ê
    °ø¾×¿°±â¿¡ ¾ç ÀüÀÚ¸¦ ÷°¡ÇÏ¿© Çü¼ºÇÑ È­ÇÐ ¹°Áú.
  • conjugated acid
    ¦ »ê, °ø¾× »ê, °áÇÕ »ê
  • corrosive acid
    ºÎ½Ä »ê
  • cyclamic acid
    »çÀÌŬ¶ó¹Î»ê
    À̰ÍÀÇ Ä®½·¿°°ú ³ªÆ®·ýÀº ÇѶ§ ºñ¿µ¾ç¼º °¨¹Ì·á·Î¼­ »çÅÁ ´ë¿ëǰÀ¸·Î ³Î¸® »ç¿ëµÇ¾úÀ¸³ª, µ¿¹° ½ÇÇè¿¡¼­ ¹æ±¤ Á¾¾ç°ú °ü·ÃÀÌ ÀÖ´Ù°í ÇÏ¿© ÇöÀç´Â À½½Ä ÷°¡¹°·Î¼­ »ç¿ëÇÏÁö ¾Ê°Ô µÇ¾ú´Ù.
  • damaluric acid
    ´Ù¸»·ç¸£ »ê
  • dehydroacetic acid
    µ¥È÷µå·Î ÃÊ»ê, µðÈ÷µå·Î¾Æ¼¼Æ®»ê
    ¿°±â¼º Ã˸ÅÀÇ Á¸Àç ÇÏ¿¡ ¾Æ¼¼Æ®»ê¿¡Æ¿ÀÇ ÃàÇÕÀ̳ª µðÄÉÅÙÀÇ ÀÌÇÕüȭ¿¡ ÀÇÇÏ¿© ÇÕ¼ºµÇ´Â È­ÇÕ¹°. ºÐÀÚ½Ä CHO. ¹é»öÀÇ Ä§»ó ¶Ç´Â ÆÇ»ó °áÁ¤À¸·Î, ³ì´ÂÁ¡ 109~111 ¡É, ²ú´ÂÁ¡ 269.9 ¡ÉÀÌ´Ù. ¹°¿¡´Â ³ìÁö ¾ÊÁö¸¸, ¿¡Å׸£¿¡´Â ³ì´Â´Ù. ½ÄǰÀÇ ¹æºÎÁ¦³ª ÇǺΠġ·áÁ¦·Î »ç¿ëµÈ´Ù.
  • deoxyribonucleic acid
    µ¥¿Á½Ã¸®º¸ ÇÙ»ê
  • dialuric acid
    ´ÙÀ̾˿ä»ê
    °áÁ¤¼­ÀÇ »ê. ¾Ë·Ï»êÀ¸·ÎºÎÅÍ ¾ò´Â´Ù.
  • diatrizoic acid
    ´ÙÀÌ¾ÆÆ®¶óÀÌÁ¶»ê
    ¹æ»ç¼± Á¶¿µÁ¦ Á¦Á¶¿¡ ¾²ÀδÙ.
  • dihydroxystearic acid
    ´ÙÀÌÇÏÀ̵å·Ï½Ã ½ºÅ׾Ƹ°»ê
    ¿Ã·¹ÀλêÀÇ »êÈ­·Î ¾òÀ¸¸ç, ÇǸ¶ÀÚÀ¯¿¡¼­ ¹ß°ßµÈ´Ù.
  • esophageal acid infusion test
    ½Äµµ»ê ÁÖÀÔ ½ÃÇè
  • essential fatty acid
    Çʼö Áö¹æ»ê
    °íµîµ¿¹°ÀÇ ¼ºÀå ¶Ç´Â °Ç°­ »óÅÂÀÇ À¯Áö¸¦ À§ÇÏ¿© ü¿Ü·ÎºÎÅÍ ¼·ÃëÇØ¾ß ÇÒ Áö¹æ»ê. ºñŸ¹Î F¶ó°íµµ ÇÑ´Ù. Áö¹æÀº ü³»¿¡¼­ ÁÖ·Î ¿¡³ÊÁö¿øÀÌ µÇ¹Ç·Î ´Ù¸¥ °ÍÀ¸·ÎºÎÅÍ Ä®·Î¸®¸¦ ÃëÇϸé Áö¹æÀº ÇÊ¿ä¾øÁö ¾ÊÀº°¡ ÇÏ´Â Àǹ®ÀÌ »ý±ä´Ù. ±×·¯³ª À½½Ä ¼Ó¿¡ Áö¹æÀÌ ÀüÇô ¾øÀ¸¸é µ¿¹°ÀÇ ¼ºÀåÀÌ Á¤ÁöÇÏ°í Æ¯À¯ÇÑ ÇǺο°ÀÌ »ý±ä´Ù. ÀÌ Áõ¼¼´Â ¸®³î»ê, ¸®³î·»»ê, ¾Æ¶ó۵·»ê Áß ¾î´À °ÍÀ» ÇÔÀ¯ÇÏ´Â Áö¹æÀ» Åõ¿©Çϸé Ä¡À¯µÈ´Ù. ±×·¡¼­ À̵é Áö¹æÀ» ¾Æ¹Ì³ë»êÀÇ ¿¹¿¡ µû¶ó Çʼö Áö¹æ»êÀ̶ó°í ÇÑ´Ù. ÀÌ»óÀÇ ¼¼ °¡Áö Áö¹æ»ê Áß¿¡¼­ ¸®³î»êÀº ÀϹÝÀûÀÎ À¯Áö¿¡ ³Î¸® ÇÔÀ¯µÇ¾î ÀÖÀ¸¹Ç·Î, º¸ÅëÀÇ Áö¹æÀ» ¼·ÃëÇϸé Áö¹æ»êÀÌ °áÇÌÇÏ´Â ÀÏÀº ¾ø´Ù.
  • ethacrynic acid
    ¿¡Å¸Å©¸°»ê
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
R enzyme <enzyme> An enzyme with action similar to that of isoamylase; it cleaves 1,6-alpha-glucosidic linkages in pullalan, amylopectin, and glycogen, and in alpha-and beta-amylase limit-dextrins of amylopectin and glycogen.
Compare: isoamylase.
Synonym: limit dextrinase, pullulanase, R enzyme.
(05 Mar 2000)
repair enzyme <enzyme, molecular biology> An enzyme that can catalyze the repair of damaged DNA; e.g., DNA ligase.
(05 Mar 2000)
repressible enzyme <biochemistry> In bacteria, an enzyme whose creation is inhibited when its reaction product is plentiful.
(09 Oct 1997)
respiratory enzyme One of those enzyme's in tissues that is a part of an oxidation-reduction system accomplishing the conversion of substrates to CO2 and H2O and the transfer of the electrons removed to O2.
(05 Mar 2000)
respiratory enzyme complexes <biochemistry> The enzymes that make up the respiratory chain: NADH Q reductase, succinate Q reductase, cytochrome reductase, cytochrome C and cytochrome oxidase.
(18 Nov 1997)
glycogen debranching enzyme system 1,4-alpha-d-glucan-1,4-alpha-d-glucan 4-alpha-d-glucosyltransferase/dextrin 6 alpha-d-glucanohydrolase. An enzyme system having both 4-alpha-glucanotransferase (ec 2.4.1.25) and amylo-1,6-glucosidase (ec 3.2.1.33) activities. As a transferase it transfers a segment of a 1,4-alpha-d-glucan to a new 4-position in an acceptor, which may be glucose or another 1,4-alpha-d-glucan. As a glucosidase it catalyses the endohydrolysis of 1,6-alpha-d-glucoside linkages at points of branching in chains of 1,4-linked alpha-d-glucose residues. Amylo-1,6-glucosidase activity is deficient in glycogen storage disease type III.
(12 Dec 1998)
restriction enzyme <enzyme, molecular biology> Class of bacterial enzymes that cut DNA at specific sites. In bacteria their function is to destroy foreign DNA, such as that of bacteriophages (host DNA is specifically modified at these sites).
Type I restriction endonucleases occur as a complex with the methylase and a polypeptide that binds to the recognition site on DNA. They are often not very specific and cut at a remote site.
Type II restriction endonucleases are the classic experimental tools. They have very specific recognition and cutting sites. The recognition sites are short, 4-8 nucleotides and are usually palindromic sequences. Because both strands have the same sequence running in opposite directions the enzymes make double stranded breaks, which, if the site of cleavage is off centre, generates fragments with short single stranded tails, these can hybridise to the tails of other fragments and are called sticky ends.
They are generally named according to the bacterium from which they were isolated (first letter of genus name and the first two letters of the specific name). The bacterial strain is identified next and multiple enzymes are given Roman numerals. For example the two enzymes isolated from the R strain of E. Coli are designated Eco RI and Eco RII.
(10 Mar 1998)
restriction enzyme cutting site <molecular biology> A specific nucleotide sequence of DNA at which a particular restriction enzyme cuts the DNA.
Some sites occur frequently in DNA (for example, every several hundred basepairs), others much less frequently (rare-cutter, for example, every 10,000 base pairs).
(10 Mar 1998)
restriction enzyme, endonuclease A protein that recognises specific, short nucleotide sequences and cuts DNA at those sites. Bacteria contain over 400 such enzymes that recognise and cut over 100 different DNA sequences. See restriction enzyme cutting site.
(05 Mar 2000)
P enzyme <enzyme> Enzyme that catalyses the sequential removal of glycosyl residues from glycogen to yield one glucose-1-phosphate per reaction. Its activity is controlled by phosphorylation (by phosphorylase kinase).
(21 Jun 2000)
membrane enzyme <enzyme> An enzyme present or embedded in a biomembrane.
(05 Mar 2000)
RNA enzyme <molecular biology> Often referred to as RNA with catalytic capacity, an enzyme made of nucleic acid not protein that catalyse chemical reactions, often the breakdown of other RNAs.
Of particular interest because of the implications for self replicating systems in the earliest stages of the evolution of (terrestrial) life.
Their discovery in the mid-1980s refuted the concept that only proteins could be biological catalysts. There is potential for their use as pharmaceuticals and industrial catalysts.
(13 Nov 1997)
microparticle enzyme immunoassay A technique in which the solid-phase support consists of very small microparticles in liquid suspension. Specific reagent antibodies are covalently bound to the microparticles. Antigen, if present, is then "sandwiched" between bound antibodies and antigen-specific, enzyme-labelled antibodies. Antigen-antibody complexes are detected and quantitated by analysis of fluorescence from the enzyme-substrate interaction.
Acronym: MEIA
(05 Mar 2000)
citrate cleavage enzyme ATP citrate (pro-3S)-lyase
phosphorylase-rupturing enzyme <enzyme> An enzyme that deactivates glycogen phosphorylase a by releasing inorganic phosphate and phosphorylase b, the inactive form.
Chemical name: (Phosphorylase a) phosphohydrolase
Registry number: EC 3.1.3.17
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á